Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 27th March 2019 from 11:00 AM to 1:00 PM (GMT).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.

Issue 24, 2013
Previous Article Next Article

Quintuple-modality (SERS-MRI-CT-TPL-PTT) plasmonic nanoprobe for theranostics

Author affiliations


A unique quintuple-modality theranostic nanoprobe (QMT) is developed with gold nanostars for surface-enhanced Raman scattering (SERS), magnetic resonance imaging (MRI), computed tomography (CT), two-photon luminescence (TPL) imaging and photothermal therapy (PTT). The synthesized gold nanostars were tagged with a SERS reporter and linked with an MRI contrast agent Gd3+. In vitro experiments demonstrated the developed QMT nanoprobe to be a potential theranostic agent for future biomedical applications.

Graphical abstract: Quintuple-modality (SERS-MRI-CT-TPL-PTT) plasmonic nanoprobe for theranostics

Back to tab navigation

Supplementary files

Publication details

The article was received on 21 Jul 2013, accepted on 19 Sep 2013 and first published on 23 Sep 2013

Article type: Communication
DOI: 10.1039/C3NR03762B
Citation: Nanoscale, 2013,5, 12126-12131

  •   Request permissions

    Quintuple-modality (SERS-MRI-CT-TPL-PTT) plasmonic nanoprobe for theranostics

    Y. Liu, Z. Chang, H. Yuan, A. M. Fales and T. Vo-Dinh, Nanoscale, 2013, 5, 12126
    DOI: 10.1039/C3NR03762B

Search articles by author